Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 7
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Allianc; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammat… See abstract for full author list ➔ Izadi Z, et al. JAMA Netw Open. 2021 Oct 1;4(10):e2129639. doi: 10.1001/jamanetworkopen.2021.29639. JAMA Netw Open. 2021. PMID: 34661663 Free PMC article.
Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology.
Temiz Karadag D, Yalcinkaya Y, Akdogan A, Avanoglu A, Bes C, Birlik AM, Cefle A, Erdogan M, Hatemi G, Icacan OC, Inanc M, Inanc N, Koca SS, Kucuksahin O, Ozgen M, Sari A, Sahin A, Senel S, Tufan A, Ugurlu S, Yargucu Zihni F, Yolbas S, Hamuryudan V. Temiz Karadag D, et al. Among authors: icacan oc. Clin Exp Rheumatol. 2023 Aug;41(8):1679-1687. doi: 10.55563/clinexprheumatol/ce13vk. Epub 2023 Jul 19. Clin Exp Rheumatol. 2023. PMID: 37470234 Free article.
COVID-19 Among Patients With Inflammatory Rheumatic Diseases.
Esatoglu SN, Tascilar K, Babaoğlu H, Bes C, Yurttas B, Akar S, Pehlivan O, Akleylek C, Tecer D, Seyahi E, Yuce-Inel T, Alpay-Kanitez N, Bodakci E, Tekgoz E, Colak S, Bolek EC, Koca SS, Kalyoncu U, Icacan OC, Ugurlu S, Oz HE, Hamuryudan V, Hatemi G; Turkish Society for Rheumatology COVID-19 Registry Investigators. Esatoglu SN, et al. Among authors: icacan oc. Front Immunol. 2021 Apr 16;12:651715. doi: 10.3389/fimmu.2021.651715. eCollection 2021. Front Immunol. 2021. PMID: 33936073 Free PMC article.
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.
Karadag O, Farisogullari B, Yagiz B, Erden A, Ademoglu Z, Kimyon G, Bilge NS, Icacan OC, Kilic L, Coskun BN, Ersozlu ED, Kucuksahin O, Mercan R, Koca SS, Gonullu E, Cinar M, Akar S, Emmungil H, Kasifoglu T, Bes C, Omma A, Pehlivan Y, Kiraz S, Ertenli I, Dalkilic E, Kalyoncu U. Karadag O, et al. Among authors: icacan oc. Clin Exp Rheumatol. 2024 Jan;42(1):130-137. doi: 10.55563/clinexprheumatol/2h6ma1. Epub 2023 Aug 29. Clin Exp Rheumatol. 2024. PMID: 37650346 Free article.
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.
Mert A, Vahaboğlu H, Arslan F, Batirel A, Saraçoğlu KT, Bastug A, Çağatay A, Irmak İ, Dizman GT, Ertenli İ, Altunal LN, Sengel BE, Bayram M, Omma A, Amikishiyev S, Aypak A, Bes C, Bolukçu S, Içten S, Topeli A, Bektaş M, Arslan BY, Öztürk S, Çomoğlu Ş, Aydin S, Küçükşahin O, Içaçan OC, Ince B, Aghamuradov S, Mutlu MY, Şimşek F, Emre S, Ustun C, Ergen P, Aydin Ö, Koç MM, Sevindik ÖG, Odabaşı Z, Korten V, Bodur H, Güner R, Ünal S, Kocak M, Gül A. Mert A, et al. Among authors: icacan oc. Rheumatol Int. 2022 Mar;42(3):457-467. doi: 10.1007/s00296-021-04965-6. Epub 2021 Sep 13. Rheumatol Int. 2022. PMID: 34515808 Free PMC article.
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study.
Izadi Z, Gianfrancesco MA, Schmajuk G, Jacobsohn L, Katz P, Rush S, Ja C, Taylor T, Shidara K, Danila MI, Wysham KD, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Al-Emadi S, Sparks JA, Hsu TY, Patel NJ, Wise L, Gilbert E, Duarte-García A, Valenzuela-Almada MO, Ugarte-Gil MF, Ljung L, Scirè CA, Carrara G, Hachulla E, Richez C, Cacoub P, Thomas T, Santos MJ, Bernardes M, Hasseli R, Regierer A, Schulze-Koops H, Müller-Ladner U, Pons-Estel G, Tanten R, Nieto RE, Pisoni CN, Tissera YS, Xavier R, Lopes Marques CD, Pileggi GCS, Robinson PC, Machado PM, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Gore-Massy M, Wallace ZS, Yazdany J; COVID-19 Global Rheumatology Alliance Registry. Izadi Z, et al. Lancet Rheumatol. 2022 Sep;4(9):e603-e613. doi: 10.1016/S2665-9913(22)00192-8. Epub 2022 Jul 25. Lancet Rheumatol. 2022. PMID: 35909441 Free PMC article.
20 results